4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001209191-21-008739
Chief Executive Officer bought 1,500 shares at $20.00 ($30,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schatzman Randall C Chief Executive Officer | 2021-02-09 | Purchase | +1,500 | $20.00 | $30,000 | 1,500 | D: show line 1 in the form |
| Open-market purchases · 1,500 sh · avg $20.00 · $30,000 | |||||||
Loading xslF345X03/doc4.xml…